Factor XI deficiency in women

Area of Science:

• Hematology
• Genetics
• Obstetrics & Gynecology

Background:

• Factor XI (FXI) deficiency is a rare, autosomal bleeding disorder primarily observed in specific populations.
• Individuals with FXI deficiency experience unpredictable bleeding, often triggered by surgical procedures, trauma, or other hemostatic challenges.
• Women with FXI deficiency face heightened risks of excessive bleeding during menstruation, childbirth, and post-operative recovery.

Purpose of the Study:

• To review current research on managing Factor XI deficiency in women.
• To highlight the importance of multidisciplinary collaboration for optimizing patient care.
• To discuss the implications of FXI deficiency in pregnancy and menstrual health, and the role of screening in cases of menorrhagia.

Main Methods:

• Literature review of current research.
• Analysis of data concerning FXI deficiency and pregnancy.
• Examination of menstrual problems and screening strategies for menorrhagia.

Main Results:

• FXI deficiency presents variable bleeding risks, particularly in women.
• Pregnancy and childbirth necessitate careful management strategies for women with FXI deficiency.
• Screening for FXI deficiency is important for women with heavy menstrual bleeding (menorrhagia).

Conclusions:

• Increased awareness and collaboration among hematologists, obstetricians, and gynecologists are vital.
• Established management guidelines are essential for minimizing bleeding risks in women with FXI deficiency.
• Screening and proactive management can significantly improve outcomes for affected women.